Posted February 16, 2021

Seller of BioCBD+ Products Warned for COVID-19 and Drug Claims

On February 11, 2021, the FDA issued a warning letter to Evolved Ayurvedic Discoveries, Inc./BioCBDPlus following a review of the company's website, which found statements made about the company's products BioCBD+ Total Body Care, BioCBD+ Topical Oil Muscle & Joint Support, and BioCBD+ Peace Vape to be drug claims. In addition, the products were sold with unsupported claims that they can treat coronavirus (COVID-19).

The FDA has previously stated: "There currently are no vaccines, pills, potions, lotions, lozenges or other prescription or over-the-counter products available to treat or cure coronavirus disease 2019 (COVID-19)."

BioCBD+ products were promoted with statements such as "May Support Depression and Mood Disorders," "Reduces the risk of osteoporosis and osteoarthritis," "CBD for autism could help because CBD is a powerful antioxidant with neuroprotective properties that protect the brain against neurodegenerative disorders," and "As COVID-19 spreads around the world, customers are asking us how CBD can help... the good news is, a healthy immune system may support you during this pandemic, and CBD is great for immune support."

See ConsumerLab's answer to the question: What are natural remedies for coronavirus (COVID-19)? Do supplements like zinc, vitamin C, or herbals work?

Also see ConsumerLab's CBD and Hemp Extract Supplements Review for tests of related products.

In addition, the CBD products were found to be misbranded because they do not contain adequate directions for safe use, as required by federal regulations.

For more information, use the link below.

Warning Letter: Evolved Ayurvedic Discoveries, Inc./BioCBDPlus

See Related Warnings:

FDA Warns Seller of Vitamin D and More for COVID-19 Claims

FDA Warns Seller of Vitamin D, Curcumin and CoQ10 Promoted for Treating COVID-19

Seller of Vitamin C, Elderberry, Silver, and More Warned for COVID-19 Claims

Niagen Cannot Be Promoted to Prevent or Treat COVID-19, Warns FDA

Silver Cannot Be Promoted to Prevent or Treat COVID-19